M. Liu et al., TRANSCRIPTIONAL ACTIVATION OF THE CDK INHIBITOR P21 BY VITAMIN-D-3 LEADS TO THE INDUCED-DIFFERENTIATION OF THE MYELOMONOCYTIC CELL-LINE U937, Genes & development, 10(2), 1996, pp. 142-153
The hormonal form of vitamin D, 1,25-dihydroxyvitamin D-3, acting thro
ugh its cognate nuclear receptor (vitamin D-3 receptor, VDR) will indu
ce myeloid leukemic cell lines to terminally differentiate into monocy
tes/macrophages. Because VDR acts by transcriptionally regulating resp
onsive genes in a ligand-dependent manner, we sought target genes of t
he receptor that initiate the differentiation process in response to l
igand. We screened a cDNA library prepared from the myelomonocytic U93
7 cell line with probes generated from either 1,25-dihydroxyvitamin D-
3-treated or untreated cells. We report here that a candidate clone th
at hybridized differentially is the Cdk inhibitor p21(WAF1, CIP1). Fur
thermore, we show that p21 is transcriptionally induced by 1,25-dihydr
oxvitamin D-3 in a VDR-dependent, but not p53-dependent, manner, and w
e identify a functional vitamin D response element in the p21 promoter
. Transient overexpression of p21 and/or the related Cdk inhibitor p27
in U937 cells in the absence of 1,25-dihydroxvitamin D-3 results in t
he cell-surface expression of monocyte/macrophage-specific markers, su
ggesting that ligand-modulated transcriptional induction of the p21 ge
ne facilitates the induced differentiation of this monoblastic cell li
ne. We believe that this is the first report demonstrating that the ec
topic overexpression of a Cdk inhibitor such as p21 or p27 directly le
ads to a terminal differentiation program.